Amarantus Bioscience Holdings Inc (AMBS)

[MUKA1]

For whatever it's worth, I think his comment was referring to a question I, and perhaps others, sent in. I got registered early enough for the webinar to be able to forward Q's for possible response at the end of the webinar.

Not sure of others, but for myself, my question was fairly open ended trying to dig for intentions in continued focus on neurotrophic factors given the very recent(at the time) Ceregene/Neuturin disappointing results. I thought his comments were very promising.